HCWB News

55 IPOs raised $15.5 billion in the most active July since 1999 and the biggest for proceeds ever. The month’s IPOs were joined by 26 SPACs. Healthcare was the most active sector with 25 IPOs, mostly biotechs, as well as medical device makers and health service providers. Robinhood Markets produced the largest deal, raising $2.1 billion. The month’s IPOs averaged a 9%...read more

IPO activity continued at a record pace this past week with 19 IPOs, marking the fourth week in 2021 with at least 17 US IPOs, the most since the year 2000. With the August lull around the corner, the pipeline saw less activity than usual; five IPOs and 13 SPACs submitted initial filings. Protein therapy platform Absci (ABSI) priced at the midpoint to raise...read more

HCW Biologics, a Phase 2 biotech developing novel immunotherapies for cancer, raised $56 million by offering 7.0 million shares at $8, the low end of the range of $8 to $10. The company had originally planned to raise $50 million, but upsized the share offering by 25%. Directors and existing shareholders, including CEO, CFO, and CSO, had indicated an interest in purchasing up to...read more

HCW Biologics, a Phase 2 biotech developing novel immunotherapies for cancer, announced terms for its IPO on Wednesday. The Miramar, FL-based company plans to raise $50 million by offering 5.6 million shares at a price range of $8 to $10. At the midpoint of the proposed range, HCW Biologics would command a fully diluted market value of $314 million. HCW is focused on...read more